Cytek Biosciences Inc (CTKB)
6.27
-0.11
(-1.72%)
USD |
NASDAQ |
May 08, 16:00
6.265
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Shareholders Equity (Quarterly): 393.06M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 393.06M |
| September 30, 2023 | 415.52M |
| June 30, 2023 | 424.18M |
| March 31, 2023 | 423.46M |
| December 31, 2022 | 425.30M |
| September 30, 2022 | 416.45M |
| June 30, 2022 | 411.03M |
| Date | Value |
|---|---|
| March 31, 2022 | 407.24M |
| December 31, 2021 | 405.04M |
| September 30, 2021 | 402.88M |
| June 30, 2021 | -11.30M |
| March 31, 2021 | -15.07M |
| December 31, 2020 | -16.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.03M
Minimum
Dec 2020
425.30M
Maximum
Dec 2022
313.98M
Average
407.24M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Ainos Inc | 24.45M |
| OpGen Inc | 2.677M |
| Zomedica Corp | 240.02M |
| LENSAR Inc | 33.43M |
| Eargo Inc (DELISTED) | 45.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.46M |
| Total Liabilities (Quarterly) | 101.39M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 6.973 |
| Net Debt Paydown Yield | -0.04% |